
Physician-reviewed TRT education
Turning 50 is not, by itself, a reason to start testosterone. TRT is intended for appropriately evaluated men with compatible symptoms and consistently low testosterone—not as a routine anti-aging medication.
Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

A 50-year-old man should consider testosterone therapy only when there is a legitimate clinical indication. Major guidelines recommend diagnosing testosterone deficiency from compatible symptoms or signs plus consistently low testosterone concentrations measured appropriately.
Fatigue, weight gain, reduced libido or poor exercise performance can occur with low testosterone, but they can also result from sleep apnea, obesity, depression, medications, thyroid disease, diabetes and other conditions. The evaluation matters as much as the testosterone number.
Average testosterone concentrations tend to decline with aging, but the pattern varies substantially among men. Age alone does not establish hypogonadism, and an age-related decrease does not automatically require medication.
Obesity, chronic illness, poor sleep, obstructive sleep apnea, certain medications and changes in overall health can also lower testosterone. Some of these factors may be reversible. See Normal Testosterone Levels by Age for age-related reference information and its limits.
The American Urological Association recommends using a total testosterone level below 300 ng/dL as a reasonable diagnostic cutoff, but the diagnosis requires more than one isolated result. Testosterone should generally be measured on two separate occasions, typically in the morning, and interpreted alongside symptoms and clinical context.
Depending on the findings, additional testing may include LH, prolactin or other studies to help distinguish primary testicular dysfunction from hypothalamic or pituitary causes. Learn about testosterone testing and evaluation at NovaGenix.
See our complete testosterone replacement therapy guide.
Symptoms that may justify evaluation include reduced sexual desire, fewer spontaneous erections, erectile difficulties, unexplained loss of muscle or strength, anemia, reduced bone density and certain changes in energy or mood. However, many of these symptoms are nonspecific.
A clinician should avoid assuming that every symptom experienced in the 40s or 50s is caused by testosterone.
In men with true testosterone deficiency, treatment may improve sexual symptoms and can have beneficial effects on anemia, bone density and body composition in selected patients. Effects on energy, mood and physical function are more variable.
The goal is not to make a 50-year-old feel 20 again or to maximize a laboratory value. The goal is to treat clinically meaningful androgen deficiency while minimizing adverse effects.
Testosterone should not be prescribed solely to counter normal aging, increase gym performance or push testosterone into supraphysiologic ranges. FDA-approved testosterone products are indicated for men with deficient or absent endogenous testosterone associated with specified medical conditions; labeling has historically distinguished this from uncomplicated age-related decline.
For men with borderline results, addressing sleep, weight, medications and metabolic health may be an important part of the evaluation before committing to long-term therapy.
Important considerations include increased hematocrit, acne or oily skin, edema, gynecomastia, blood-pressure effects, suppression of sperm production and testicular volume, and the need for ongoing monitoring. Individual cardiovascular and prostate history also matter.
TRT is not a “set it and forget it” medication. Our long-term TRT safety guide explains the evidence, risks and ongoing monitoring.
The large TRAVERSE trial enrolled middle-aged and older men with hypogonadism and preexisting or high cardiovascular risk. Testosterone treatment was noninferior to placebo for major adverse cardiovascular events in that studied population, providing important reassurance about appropriately prescribed therapy. The trial does not mean testosterone is risk-free or appropriate for every man.
FDA has also required class-wide testosterone labeling regarding increases in blood pressure. See our guide to testosterone and blood pressure.
Current evidence does not support the old simplistic idea that appropriately prescribed TRT automatically causes prostate cancer. However, prostate assessment and monitoring remain important, particularly in older men and those with elevated baseline risk.
Men with concerning PSA findings, a prostate nodule or known prostate cancer need individualized evaluation before treatment decisions. TRT should not be used to bypass appropriate prostate assessment.
Testosterone can stimulate red blood cell production and raise hematocrit. Baseline hemoglobin and hematocrit should be assessed, and the AUA recommends intervention when hematocrit reaches 54% or higher during therapy.
Other contributors such as smoking, hypoxia and obstructive sleep apnea should also be considered. Read our detailed guide to hematocrit on TRT.
Age 50 does not mean fertility is irrelevant. Exogenous testosterone suppresses LH and FSH and can substantially reduce sperm production. A man who may want biological children should discuss fertility before beginning TRT.
Alternative approaches may be considered in selected men depending on the cause of low testosterone and fertility goals. See TRT and fertility.
A proper evaluation commonly includes symptoms, repeat testosterone testing, medical and medication history, CBC/hematocrit and assessment for contraindications or conditions that could alter the decision. PSA/prostate evaluation may be appropriate based on age and risk. Fertility goals should be discussed before treatment.
Untreated severe obstructive sleep apnea, markedly elevated hematocrit, recent major cardiovascular events and certain prostate findings can materially affect treatment decisions.
Follow-up should assess whether symptoms actually improve, whether testosterone concentrations are appropriate for the prescribed formulation, and whether adverse effects develop. Monitoring commonly includes CBC/hematocrit and other testing based on age, risk factors and formulation.
Dose adjustments should be based on the entire clinical picture rather than trying to achieve the highest possible testosterone number. See TRT dosing principles.
No. Age 50 is not inherently too old. The question is whether testosterone deficiency has been appropriately diagnosed and whether the expected benefits outweigh the individual risks.
Routine population screening is not universally recommended. Testing is most useful when symptoms, signs or medical circumstances raise a reasonable suspicion of testosterone deficiency.
TRT can affect body composition in hypogonadal men, but it is not a primary weight-loss treatment. Nutrition, physical activity, sleep and metabolic health remain central.
Testosterone can increase lean mass in men with deficiency, but changes in functional strength vary. TRT should not be prescribed solely as a performance-enhancing strategy.
Not necessarily, but exogenous testosterone suppresses endogenous production while it is being used. Long-term treatment decisions should be revisited based on diagnosis, benefit, adverse effects and patient goals.
NovaGenix can review symptoms, repeat testosterone testing, medical history, fertility goals and treatment options before determining whether TRT is appropriate. Learn about Dr. Timothy Mackey and NovaGenix Health & Wellness.
Call 561-277-8260 | Text NovaGenix | Schedule a Consultation
This article is educational and does not replace individualized medical advice, diagnosis or treatment.
Speak with NovaGenix about physician-led evaluation, testing, and treatment options in Jupiter, Florida.
Medical disclaimer: This article is for general educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Reading it does not create a physician-patient relationship. Always consult a qualified healthcare professional about your individual circumstances, and never delay seeking care because of something you read here. If you are experiencing a medical emergency, call 911. Read our full Medical Disclaimer.


609 N Hepburn avenue suite 106. Jupiter, Florida 33458
609 N Hepburn avenue suite 106. Jupiter, Florida 33458
561-277-8260
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed